1 | Study | 1.54% | |
2 | Cancer | 1.27% | |
3 | Health | 1.1% | |
4 | New | 0.84% | |
5 | BMC | 0.75% | |
6 | Disease | 0.72% | |
7 | Patients | 0.7% | |
8 | Case | 0.56% | |
9 | HIV | 0.45% | |
10 | Report | 0.44% | |
11 | May | 0.42% | |
12 | Treatment | 0.4% | |
13 | Africa | 0.37% | |
14 | MD | 0.37% | |
15 | Risk | 0.35% | |
16 | Clinical | 0.33% | |
17 | Breast | 0.31% | |
18 | AI | 0.3% | |
19 | Infectious | 0.3% | |
20 | Trial | 0.28% | |
21 | Liver | 0.28% | |
22 | Syndrome | 0.28% | |
23 | COVID-19 | 0.24% | |
24 | Public | 0.24% | |
25 | Diabetes | 0.24% | |
26 | Review | 0.24% | |
27 | Therapy | 0.24% | |
28 | Prostate | 0.23% | |
29 | Rare | 0.23% | |
30 | Heart | 0.23% | |
31 | Acute | 0.21% | |
32 | Children | 0.21% | |
33 | World | 0.21% | |
34 | Drug | 0.21% | |
35 | Patient | 0.21% | |
36 | Vaccine | 0.21% | |
37 | Human | 0.19% | |
38 | Research | 0.19% | |
39 | Chronic | 0.19% | |
40 | Development | 0.19% | |
41 | Potential | 0.19% | |
42 | Care | 0.19% | |
43 | Alzheimers | 0.19% | |
44 | Use | 0.19% | |
45 | Shows | 0.19% | |
46 | Not | 0.19% | |
47 | Against | 0.19% | |
48 | Malaria | 0.19% | |
49 | AllAfrica | 0.19% | |
50 | Parkinsons | 0.19% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
Fibrin Immunotherapy's Potential for Treating Traumatic Brain Injury
Technology Networks
2024-04-22 17:15:54
Immunotherapy Safely Boosted with Particle-Bound Cytokines in Tumor Models
Genetic Engineering & Biotechnology News
2024-04-21 22:00:33
Novel Radiotherapy Technology Shows “Great Advantage” in Brain Cancer
Cancer Network
2024-04-21 01:09:03
Study: Chemotherapy to Treat Breast Cancer Increases Risk of Lung Cancer
Pharmacy Times
2024-04-20 00:07:06
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
AJMC.com Managed Markets Network
2024-04-19 05:29:24
Trial for immunotherapy drug shows promise for aggressive breast cancer
Medical Xpress
2024-04-19 02:24:04
Study Uncovers Potential Immunotherapy Approach for Rare Eye Cancer
Technology Networks
2024-04-18 18:21:37
Survival Rates in CLL: Targeted Agents vs Fludarabine Combo Therapy Study
AJMC.com Managed Markets Network
2024-04-18 07:04:25
Cureus
2024-04-18 05:04:13